Glucovis Eye Drop 0.25% contains Betaxolol Hydrochloride, a selective beta-1 adrenergic receptor blocker used in the management of ocular hypertension and open-angle glaucoma. It is formulated to effectively reduce elevated intraocular pressure (IOP), thereby helping to prevent optic nerve damage and progressive vision loss associated with glaucoma.

Glucovis Eye Drop is suitable for long-term use and is particularly beneficial for patients who require intraocular pressure control with a reduced risk of respiratory side effects compared to non-selective beta-blockers.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Therapeutic Class

Ophthalmic Anti-glaucoma Agent (Selective Beta-Blocker)

Pharmacology

Betaxolol Hydrochloride is a cardioselective beta-1 adrenergic receptor antagonist. When applied topically to the eye, it reduces intraocular pressure by decreasing aqueous humor production in the ciliary body. Unlike non-selective beta-blockers, betaxolol has minimal activity on beta-2 receptors, which are responsible for bronchial smooth muscle relaxation. This selectivity makes it a safer option for patients with mild respiratory conditions.

Betaxolol does not significantly affect pupil size or accommodation, allowing patients to maintain clear vision during treatment. After ocular administration, systemic absorption is minimal, reducing the likelihood of systemic adverse effects.

Indications

Glucovis Eye Drop 0.25% is indicated for:

• Open-angle glaucoma

• Ocular hypertension

• Reduction of elevated intraocular pressure

Dosage and Administration

The usual recommended dosage is one drop in the affected eye(s) twice daily, or as directed by an ophthalmologist. Patients should wash their hands before use and avoid touching the dropper tip to prevent contamination. If multiple ophthalmic medications are used, an interval of at least 5 minutes should be maintained between applications.

Benefits and Features

• Effectively lowers intraocular pressure

• Selective beta-1 blocker with reduced respiratory side effects

• Does not cause pupil constriction or blurred vision

• Suitable for long-term glaucoma management

• Well tolerated when used as prescribed

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Use in Special Populations

• Elderly patients: Generally well tolerated; monitoring is recommended

• Patients with respiratory disease: Use with caution, although risk is lower compared to non-selective beta-blockers

• Pregnancy and lactation: Use only if clearly needed and prescribed by a physician

Side Effects

Most patients tolerate Glucovis Eye Drop well. Possible side effects may include:

• Mild eye irritation or discomfort

• Burning or stinging sensation after instillation

• Dry eyes

• Blurred vision (temporary)

Rare systemic effects such as bradycardia or fatigue may occur due to systemic absorption.

Precautions and Warnings

• Not recommended in patients with severe cardiac conditions unless advised by a physician

• Use with caution in patients with diabetes, as beta-blockers may mask symptoms of hypoglycemia

• Regular monitoring of intraocular pressure is essential

• Do not discontinue abruptly without medical advice

Storage

Store in a cool and dry place below 30°C. Protect from light. Keep the bottle tightly closed and out of reach of children.